Association Between HBV DNA Level and Intrahepatic HBcAg Protein Expression of Hepatocytes in Patients with Chronic Hepatitis B by Serevina, D. (Devy) et al.
Volume 11, Number  2, August 2010 79
ORIGINAL ARTICLE
INTRODUCTION
Chronic hepatitis caused by viral infection is still
becoming a health issue in the world. It is assumed
that about 4–20% people worldwide, especially in Asia
– Africa regions have been infected by chronic
hepatitis. Hepatitis B virus (HBV) has infected
approximately 350 million people worldwide and has
been reported as a major cause of chronic hepatitis,
liver cirrhosis, and even hepatocellular carcinoma
(HCC).1-3
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ABSTRACT
Background: Correlation between serum Hepatitis B viral deoxyribonucleic acid (HBV DNA) and
hepatitis B core antigen (HBcAg) protein expression in the liver regarding hepatitis B e-antigen (HBeAg)
status have not been well studied. This study was aimed to demonstrate association between serum HBV
DNA and HBeAg levels with HBcAg expressions in the liver.
Method: A total of 55 naive chronic hepatitis B (CHB) patients were enrolled. All samples were tested
for HBeAg serum by serological test enzyme-linked immunosorbent assay (ELISA) and HBV DNA was
determined by polymerase chain reaction (PCR) HBsAg and HBcAg were evaluated immunohistochemically
in the liver tissue.
Results: Of 55 patients, 44 (80%) were HBeAg positive and 11 (20%) were HBeAg negative. There
was a positive correlation between serum HBV DNA and HBcAg expression in the nuclei (r = 0.383;
p = 0.004). There was association between HBcAg expression in the nucleus and qualitative HBeAg
(p = 0.017).
Conclusion: In the patient with chronic HBV, there is a very significant positive correlation between
the level of viral replication and HBcAg expression in the nucleus of hepatocytes. Moreover, there is
association between HBcAg expression in the hepatocytes nucleus and HBeAg serum level. These
finding lead to the proposition that nucleus localization of HBcAg protein function to amplify the pool of
cccDNA in the replication cycle of HBV.
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Patients with HBV infection have differentiation in
their severity of illness, which is related to various
factors that play a role in liver damage.
A multidisciplinary integration is necessary in
determination of chronic hepatitis B prognosis and the
decision to provide viral eradication therapy, including
physical examination, serum hepatitis B e-antigen
(HBeAg) and serum hepatitis B surface antigen
(HBsAg) tests, blood chemistry test in order to evaluate
liver function as well as the abdominal imaging.
Moreover, in determining treatment for chronic hepatitis
B patients, utilization of some parameters should be
considered such as liver function test and examination
with transient elastography. Liver biopsy for determining
treatment has only been used in some health centers. It
is still being an essential examination and scientifically
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accountable for evaluating the severity of liver damage
compared to blood chemistry test and viral load.
It has been known that HBV replication cycle is
not directly causing cytotoxicity and cytopathic effects
in liver cells.4,5 Currently, it has been noticed that the
host immune responses played a role as viral antigen,
which can be shown when liver cells have been
infected. However, the immune response to HBV and
its pathogenesis has not been understood completely.5
HBV particles/virions are bound to surface
receptors of the liver cells and after internalized to
cells membranes, the virus core particles will be
delivered to liver nucleus where its genomes converted
to the covalently closed circular DNA (cccDNA), a
template for viral mRNA. Subsequently, the mRNA is
translated in cytoplasm resulting in encapsidation/virus
enveloping, viral core, polymerase, and protein X. One
of mRNA, the so-called pregenomic mRNA is used
for synthesizing the core (nucleocapsid sub-unit) and
reverse-transcriptase of viral protein.
In cytoplasm, the nucleocapsid of synthesized virus
will be combined with viral RNA genomes to be
packaging RNA. The RNA will experience reverse –
transcription into the viral DNA. The resulted core
particle will then be released to the endoplasmic
reticulum where it forms capsule or envelope
encapsulating the viral DNA particles. Some of the
complete viral particles or mature core particles will
be excreted out of cells and others may have the
genomes cycle repetition by re-entering the nucleus
of liver cells, which consequently converted into
cccDNA again.5,6,7
The C gene is a HBV’s genome component that
coded the nucleocapsid protein transformation, i.e.
HbcAg, which will stay in hepatocytes and paired to
the complete virions; while  pre core area is associated
to HBeAg polypeptide secretion into blood. Thus, the
existence of hepatitis B core antigen (HBcAg) in liver
cells is correlated to the presence of HBeaAg as a
marker of HBV replication.8
Viral load examination is used for monitoring the
presence of HBV replication which actually persistent
during chronic HBV infection, also to evaluate the
reduction of viral load as a result of antiviral and/or
interferon treatment. 9,10
Currently, several methods for evaluating virus
replication in tissues have been known, including
cccDNA and pre–genomic tests which are more
accurate. However, since there was limitation of
funding and equipments in our country, our study
utilized immunohistochemistry (IHC) methods to detect
HBcAg as a viral replication marker in liver tissues as
it was technically easy with affordable cost so that it
could be conducted in Indonesia. IHC methods and
serology test will provide more strength in the chronic
hepatitis B diagnostics.
Some investigators have studied about viral
expression in liver tissues using HBcAg marker. They
found that HBcAg expression and assay intensity in
liver biopsy may reveal HBV infection which is
correlated to viral replication degree.11,12,13 Kim et.al.
found that HBcAg expression degree in the nucleus
of hepatocytes was effected by viral load.3 The
presence of HBcAg in hepatocytes nucleus was
correlated to HBeAg, as HBV replication markers. 3,14
The aim of this study was to find the quantitative
correlation between HBcAg expression in hepatocytes
nucleus and viral load as well as its qualitative
association with HbeAg serum level in patients with
chronic hepatitis B infection.
METHOD
The design was analytical cross–sectional study. It
was conducted between August 2009 and October 2010
in Department of Anatomical Pathology Cipto
Mangunkusumo hospital. The collected samples were
microscopic slides and paraffin blocks of patients who
had been clinically diagnosed with chronic hepatitis B
during 2007 – 2008. Inclusion criteria were (1). Slides
and paraffin blocks of patients who had  complete
clinical data, serum HBeAg level, viral load, and serum
HBsAg level. (2). Paraffin blocks with an adequate
size of tissue for histological evaluation and IHC test.
Exclusion criteria included slide and paraffin blocks of
patients who had been diagnosed with concomitant
infections, such as hepatitis B and C as well as HIV
based on their medical records.
All cases had undergone the serology examination
(ELISA) to measure the qualitative serum HBeAg
level and PCR testing (Cobas TaqMan 48) to measure
the quantitative serum HBV DNA level. IHC assay
was performed by using avidin-biotin methods with
HBcAg primary antibody (Dakkopatts, Copenhagen,
Denmark).
IHC assay with primary antibody HBcAg was first
prepared by deparaffinization for 5 minutes, rehydration
for 4 minutes, washing with flowing water, endogenous
peroxide blocking with hydrogen peroxide 0.3% in tris
buffered saline (TBS) for 30 minutes, washing with
flowing water for 5 minutes, heating the retrieval
antigen using the 750 watt oven for 10 minutes, soaking
with PBS pH 7.4 for 30 minutes, sniper background
blocking for 15 minutes, primary antibody incubation
for 1 night (HBcAg) by 1: 1,500 dilution, washing with
PBS pH 7.4 for 15 – 30 minutes, secondary antibody
incubation (universal link) for 15 – 30 minutes, washing
in PBS pH 7.4, performing standard avidin–biotin
peroxide complex technique with Trekavidin–HRP label
for 15 – 30 minutes, washing in PBS pH 7.4, enhancing
with diaminobenzidine (DAB) for 2 – 5 minutes,
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washing with flowing water and counterstaining with 
hematoxyllin meyer for 2 minutes, washing with flowing  
water, lithium carbonate saturation, washing with  
flowing water, dehydration for 5 minutes, clearing  
process for 5 minutes, mounting and covering with  
cover glass. 
Every assay was accompanied by negative controls  
for each case and positive controls of patients with  
chronic HBV infection as assay technique and standard  
controller. The positive HBcAg expression was shown  
by brown color in hepatocytes nucleus and then it was  
count quantitatively on 10 high power fields. Data  
analysis: all data was being expressed in the main table,  
calculated for its frequency and distribution, and  
statistical test was performed by using SPSS 17.0. The  
Spearman statistical test was used after normality test  
showed abnormal data to determine the correlation  
between numerical and numerical variables; Mann- 
Whitney was performed to determine the correlation  
between numerical and categorical variables. Limit of  
significance was determined as p  < 0.05. 
 
RESULTS 
Of 55 cases based on clinical data, there were 18 
(32.7%) female and 37 (67.3%) male subjects. The 
range age of subjects was 20-65 years. 
 
 
 
 
 
 
 
 
 
Brown in nucleus by IHC staining was regarded 
as positive cells of HBcAg (figure 1). Positive 
expression in hepatocyte nucleus was detected in 36 
cases (65.45%) (table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 1. HBcAg expression in the nucleus of hepatocytes, 400 x 
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Statistic analysis showed that there was a significant 
correlation between HBcAg expression in hepatocyte 
nucleus and viral load concentration of serum HBV 
DNA (r = 0.383; p = 0.004) (table 3). Mann-Whitney 
U test indicated a significant correlation between 
HBcAg expression in hepatocytes nucleus and 
qualitative serum HbeAg (p = 0.017) (table 3) 
HBcAg expression assessment between two 
observers showed a moderate strength of agreement, 
with a kappa coefficient value of 0.643. 
DISCUSSION 
Some literatures demonstrate that chronic hepatitis  
B in adults often occur in men at their third and fourth  
decade of life (table 1). The result of our study indicated  
that male were more likely to have the disease than  
female, which is consistent with the existing knowledge  
in literatures. 1,15 
From this study we found that IHC assay positive  
was showed by brown coloration in hepatocytes  
nucleus, which suggested expression of chronic  
hepatitis B virus in hepatocyte nucleus (intrahepatic)  
(figure 1). The statistic analysis demonstrated a  
significant correlation between HBcAg expression in  
hepatocytes nucleus and qualitative serum HBeAg  
(p = 0.017) (table 3). A similar result had also been  
found by Hsu et al who have also demonstrated  
correlation between HBcAg expression and serum  
HBeAg especially in HBeAg - seropositive patients.16  
Such results are consistent with prior opinions in which  
HBeAg formation in serum indicated the occurrence  
of viral replication activities, and this also in keeping  
with HBcAg formation in nucleus that indicated viral  
activities in hepatocyte nucleus.8,17 
The interesting point of our study is the correlation  
between HBcAg expression in hepatocytes nucleus  
and increasing titer of serum HBV DNA (r = 0.383;  
p = 0.004) (table 3).   Similar results had also been  
demonstrated by Kim et.al and Chu et al. 3,18 By this  
study, we found that HBcAg location in nucleus and  
the occurrence of HBcAg found in nucleus indicated  
that  the virus may lay dormant (quiescent); however,  
it may also indicate that the viral replication is active.  
HBcAg expression in hepatocytes nucleus is very  
important in viral replication. 18 However, the significant  
mechanism about the HBV DNA correlation with  
HBcAg expression in hepatocytes nucleus has not been  
completely clear. 
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Table. 1. Subjects baseline characteristics (n= 55) 
Variables n (%) 
Sex  
     Male 37 (67.27) 
     Female 18 (32.73) 
Age (years)  
     < 40  23 (41.82) 
     > 40  32 (58.18) 
HBeAg Serum   
     Positive 44 (80.00) 
     Negative 11 (20.00) 
 
Table. 2. HBcAg Expression in Hepatocytes 
Variable n (%) 
HBcAg expression in nucleus  
 Positive 36 (65.45) 
 Negative 19 (42.23) 
 
Table. 3. Correlation of HBV DNA viral load, HBsAg expression  
with serum HBeAg and HBcAg in hepatocytes 
HBcAg expression in 
hepatocytes  Viral load HBV 
HBeAg 
serum 
HBcAg expression in 
nucleus  r 0.383  
 p 0.004 0.017 
r: correlation   
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HBcAg is translational product of pre–core/core
gene of HBV and it is an arginine rich–carboxyl-
terminal region that has a nucleus localization signal.
After internalized to hepatocytes and converted to
uncoated virus, then it transported into nucleus, DNA
virus converted to stable DNA (cccDNA) which ready
for template of RNA pregenomic transcription. Some
of pregenomic RNA are moved into cytosol, where
viral nucleocapsid is formed and polymerated  into core
particles.3,17,18
 DNA core virus– cytoplasm package may have
re-entered to the nucleus for core cccDNA replication,
thus leads to the continuous new virions production.
Finding of correlation between HBcAg expression in
nucleus and DNA HBV viral load in this study
supported amplification mechanism of re-entry
theory.3,17,18
CONCLUSION
There was a significant correlation between HBcAg
expression in hepatocytes nucleus and DNA HBV viral
load in chronic hepatitis B patients and there was a
significant relationship between HBcAg expression in
hepatocytes nucleus and qualitative serum HBeAg.
These findings may confirm that HBcAg protein was
located in nucleus, which also has a responsibility in
cccDNA pool multiplication in replication cycle of
HBV. IHC assay for liver biopsy preparation is very
helpful for quantitative estimation of viral replication.
Therefore, we recommend the utilization of IHC in
routine assay for determining HBV diagnosis.
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